FDA Inspection
Halifax Health Medical Center Blood BankHalifax Health Medical Center Blood Bank – FDA Inspection, Sep 10, 2013
Record Details
This FDA Inspection record concerns Halifax Health Medical Center Blood Bank, with an inspection on September 10, 2013, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- September 10, 2013
- Product Type
- Biologics
View Company Profile
ID · 2ceed0c3-f505-42b3-bde5-98193b3cf447
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 847871
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Halifax Health Medical Center Blood Bank
7| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 8, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| February 7, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 23, 2017 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| March 25, 2015 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Halifax Health Medical Center Blood Bank
- FDA Inspection 1241224 - 2024-06-12
- FDA Inspection 1169294 - 2022-04-08
- FDA Inspection 1082328 - 2019-02-07
- FDA Inspection 1012289 - 2017-02-23
- FDA Inspection 919478 - 2015-03-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.